Journal of Cancer Research and Immuno-Oncology
Open Access

Current updates in Cancer and Immuno-oncology

Theodoros Michelakos^{* *}Correspondence: Theodoros Michelakos, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA, Email:

Author info »

Editorial

On behalf of the Board of the Journal of Cancer Research and Immuno-oncology and co-editors, I am glad to present the Volume 6, Issue 2 of the journal. Journal of Cancer Research and Immuno-oncology is an open access peer review journal in the field of cancer research. The journal is established in 2015 has now published 8 issues; three issues in a year. Journal of Cancer Research and Immuno-Oncology is having International Standard Serial Number (ISSN) of 2684-1266. The journal is indexed and abstracted in refSeek, Hamdard University, EBSCO A-Z. Average download per article is increasing and all these are promising signs. Now we are in this stage only through the continuous support of Editorial Board Members and intellectual generosity of the readers and contributors (authors and reviewers).

One of the objectives of this journal is to encourage publication from different streams of research that helps to enrich further the discourse on cancer and immuno-oncology. Readers can particularly notice progress made in our journal. We take this opportunity to thank the authors, editors and reviewers without them nothing is possible.

Main aims and objectives of this journal is to publish more and more quality articles of research, review, short commentary, mini reviews, case reports etc which will be very useful for the readers. We would like publish more articles related to cancer and immuno-oncology terms including cancer cells, stem cells, Tcells, Breast cancer, Lung cancer, colon cancer, leukemia, melanoma, sarcoma, carcinoma, ovarian cancer, Glioblastoma, mesothelioma, Gatrinoma and different cell therapies including adoptive cell therapy and adjuvant Immuno therapy, monoclonal antibodies etc.

Journal of Cancer Research and Immuno-oncology has editorial tracking system which made the authors easy to track their manuscript soon after the submission. Authors can track their manuscript flow easily by using the credentials provided to them. Eminent professionals from throughout the globe act as Editorial board members and reviewers of this journal. We are very thankful to the Editorial board members and reviewers who made the peer review process easily and issue release on time. We release the issues on time without any delay. The editorial team follows strict guidelines to avoid any potential bias and conflict of interest while reviewing manuscripts. Journal functions on principles of scientific excellence, publication ethics and transparency. This together we will make Journal of Cancer Research and Immuno-oncology a truly powerful publication.

In future we would like to publish articles related to COVID-19 which is pandemic and current hot topic and its discovery of vaccination is challenging for all the countries. We would like to invite articles which show the effect of corona virus on the cancer patients and the treatment given to them. As corona virus is more fatal to cancer patients most of the researchers are working hard on this to combat the situation.

With the support of authors, Editorial board members, reviewers and readers Journal of Cancer Research and Immunooncology became very successful with good number of quality articles and will reach good heights with this continuous support. The objective of JCRIO is to publish up-to-date, highquality and original research papers alongside relevant and insightful reviews. This journal aspires to be vibrant, engaging and accessible, and at the same time integrative and challenging.